Clinical trials
Stroke trials in Egypt
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
83 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 2 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 8 |
| 2023 | 9 |
| 2024 | 12 |
| 2025 | 19 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 42 |
| Unknown status | 20 |
| Recruiting | 11 |
| Enrolling by invitation | 4 |
| Not yet recruiting | 3 |
| Active, not recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cairo University | 30 |
| October 6 University | 8 |
| Ahmed Alshimy | 4 |
| Assiut University | 3 |
| Kafrelsheikh University | 3 |
| Alexandria University | 2 |
| Beni-Suef University | 2 |
| Delta University for Science and Technology | 2 |
| Middle East North Africa Stroke and Interventional Neurotherapies Organization | 2 |
| Society of Minimally Invasive Neurological Therapeutic Procedures | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stroke | 83 |
| Ischemic Stroke | 10 |
| Hemiplegia | 5 |
| Atrial Fibrillation | 4 |
| Muscle Spasticity | 3 |
| Deglutition Disorders | 2 |
| Gait Disorders, Neurologic | 2 |
| Hemorrhagic Stroke | 2 |
| Myocardial Infarction | 2 |
| Paresis | 2 |
Trials
Showing 26 to 50 of 83. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.